IDEA Collider: Innovation & Asymmetric Learning in Pharma cover image

The Misconceptions In The Pharma Industry With John L. Lamattina

IDEA Collider: Innovation & Asymmetric Learning in Pharma

00:00

Pfizer's CEO, Burles, Is the CEO of BioNTech, Inc.

Pfizer invested $2 billion in a company called BioNTech, which is developing an alternative to the flu vaccine. Pfizer CEO: "It's not going to break us" Peter Burles says he benefits from strong board of directors with Nobel Prize winners on it. He also credits Operation Warp Speed for funding early stage mRNA vaccine work.

Play episode from 29:41
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app